Clinical Trial Update: Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes salvage therapy with sunitinib, docetaxel, and platinum for metastatic or unresectable non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Sutent (sunitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Taipei Medical University Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN